Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi, L Ravanetti… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections, antiviral functions of T cells are impaired; these might be increased by …
被引用次数：143 相关文章

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Background & aims In patients with chronic hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections, antiviral functions of T cells are impaired; these might be increased by …

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi, L Ravanetti… - Gastroenterology, 2012 - infona.pl
In patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections,
antiviral functions of T cells are impaired; these might be increased by blocking T-cell co …

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi… - …, 2012 - gastrojournal.org
Background & Aims In patients with chronic hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections, antiviral functions of T cells are impaired; these might be increased by …

[引用][C] Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi… - Gastroenterology, 2012 - cir.nii.ac.jp
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of
Human Liver T Cells Against HBV, But Not HCV | CiNii Research CiNii 国立情報学研究所 学術 …

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

P Fisicaro, C Valdatta, M Massari, E Loggi… - …, 2012 - europepmc.org
Methods We assessed the effects of CD137 stimulation (via CD137L), alone or in
combination with antibodies that block PD-1 interaction with PD-L1 (anti-PD-L1), on …

[引用][C] Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi… - …, 2012 - air.unipr.it
Combined blockade of programmed death-1 and activation of CD137 increase responses of
human liver T cells against HBV, but not HCV IRIS IRIS Home Sfoglia Macrotipologie & tipologie …

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV

P Fisicaro, C Valdatta, M Massari, E Loggi… - …, 2012 - iris.unimore.it
In patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections,
antiviral functions of T cells are impaired; these might be increased by blocking T-cell co …

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV.

P Fisicaro, C Valdatta, M Massari, E Loggi… - …, 2012 - cris.unibo.it
BACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections, antiviral functions of T cells are impaired; these might be increased by …